| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.74B | 1.72B | 1.70B | 1.59B | 1.38B | 1.29B |
| Gross Profit | 870.60M | 869.10M | 822.60M | 757.20M | 701.10M | 635.30M |
| EBITDA | 112.20M | 111.00M | 177.20M | 174.60M | 213.90M | 183.00M |
| Net Income | -33.80M | -33.60M | 16.90M | 28.10M | 77.70M | 53.20M |
Balance Sheet | ||||||
| Total Assets | 1.17B | 1.18B | 1.28B | 1.36B | 1.29B | 1.07B |
| Cash, Cash Equivalents and Short-Term Investments | 18.80M | 19.10M | 13.30M | 41.90M | 46.30M | 67.20M |
| Total Debt | 251.50M | 280.40M | 328.60M | 390.60M | 391.20M | 344.50M |
| Total Liabilities | 675.70M | 675.10M | 725.70M | 796.40M | 739.20M | 655.60M |
| Stockholders Equity | 495.90M | 500.10M | 553.80M | 562.80M | 551.00M | 417.80M |
Cash Flow | ||||||
| Free Cash Flow | 155.50M | 141.50M | 121.80M | 97.90M | 71.60M | 239.10M |
| Operating Cash Flow | 199.00M | 194.70M | 167.40M | 152.30M | 118.90M | 266.60M |
| Investing Cash Flow | -61.40M | -57.20M | -46.50M | -87.00M | -98.30M | -39.00M |
| Financing Cash Flow | -153.90M | -131.70M | -139.80M | -79.20M | -41.50M | -275.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.28B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
68 Neutral | £3.36B | 9.49 | 15.14% | 1.21% | 10.51% | -7.47% | |
65 Neutral | £1.46B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
63 Neutral | £483.37M | 11.70 | 7.92% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | £336.40M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
53 Neutral | £51.43M | -28.65 | -10.09% | 2.09% | -5.97% | 14.75% |